Physician profile
Brian Guz
NPI 1174588487
$3,499.30
in general payments reported to CMS, 2019-2025
28 companies · $760 in 2025
The $760 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,059 · 2020: $92.37 · 2021: $84.51 · 2022: $460 · 2023: $510 · 2024: $533 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,803.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $532.15 | 2022-2025 | |
| Integra Gpo, LLC | $436.77 | 2019 | |
| Ferring Pharmaceuticals INC. | $424.52 | 2019 | |
| Sumitomo Pharma America, INC. | $347.89 | 2023-2025 | Gemtesa, Orgovyx |
| Merck Sharp & Dohme LLC | $312.84 | 2022-2025 | Keytruda |
| Teleflex LLC | $265.62 | 2022-2023 | Urolift |
| Astellas Pharma US INC | $216.31 | 2019-2024 | Xtandi |
| Myriad Genetic Laboratories, INC. | $140.22 | 2023 | Prolaris |
| Laborie Medical Technologies Corp. | $99.07 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Allergan, INC. | $86.85 | 2021-2022 | |
| 180 Medical, INC. | $84.93 | 2022-2024 | Gentlecath |
| Progenics Pharmaceuticals, INC. | $69.22 | 2022-2025 | |
| Boston Scientific Corporation | $57.29 | 2025 | Ams 700 |
| Dendreon Pharmaceuticals LLC | $56.87 | 2019-2024 | Provenge |
| Coloplast Corp | $44.69 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $42.79 | 2023 | |
| Antares Pharma, INC. | $40.25 | 2021-2024 | Xyosted |
| Olympus America INC. | $36.86 | 2019-2025 | Itind System |
| Photocure INC | $32.54 | 2023-2025 | Cysview |
| Urogen Pharma, INC. | $32.22 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.05 | 2023 | |
| Procept Biorobotics Corporation | $19.78 | 2024 | Aquabeam System |
| Zyla Life Sciences, INC. | $19.16 | 2019 | |
| Convatec INC. | $18.64 | 2022 | |
| Janssen Biotech, INC. | $17.78 | 2019 | |
| Tempus Ai, INC | $17.33 | 2024 | |
| Urovant Sciences INC | $14.75 | 2022 | |
| Blue Earth Diagnostics | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Guz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.